[{"address1": "National Innovation Centre", "address2": "Suite 212a 2 4 Cornwallis Street Eveleigh", "city": "Sydney", "state": "NSW", "zip": "2015", "country": "Australia", "phone": "61 2 9209 4037", "fax": "61 2 9209 4037", "website": "https://www.claritypharmaceuticals.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Clarity Pharmaceuticals Ltd, a clinical stage radiopharmaceutical company, engages in research and development of radiopharmaceuticals products for oncology in Australia and the United States. The company's lead product is SAR-bisPSMA, a theranostic radiopharmaceutical for diagnosing, staging and subsequently treating cancers that express Prostate Specific Membrane Antigen (PSMA). Its product portfolio consists SAR-Bombesin, a highly targeted pan cancer theranostic radiopharmaceutical for diagnosing, staging and subsequently treating cancers that express gastrin releasing peptide receptor (GRPr), such as prostate, breast, ovarian, urinary, small cell lung cancer, as well as glioblastoma and gastrointestinal stromal tumours; and SARTATE, a theranostic radiopharmaceutical for diagnosing, staging and subsequently treating cancers that express somatostatin receptor 2 (SSTR2). The company was incorporated in 2010 and is based in Sydney, Australia.", "fullTimeEmployees": 69, "companyOfficers": [{"maxAge": 1, "name": "Dr. Alan John Taylor Ph.D.", "title": "Executive Chairman", "fiscalYear": 2025, "totalPay": 1000615, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Matthew  Harris BSc., M.B.A., Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2025, "totalPay": 127657, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa  Sadetskaya", "title": "Director of Corporate Communications.", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Mary  Bennett", "title": "Head of People & Culture", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Shaemus  Gleason", "title": "Executive Vice President of Operations", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Othon  Gervasio", "title": "Chief Medical Officer", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eva  Lengyelova", "title": "Executive Vice President of Clinical Development", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert  Vickery", "title": "Company Secretary", "fiscalYear": 2025, "totalPay": 106536, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 6, "shareHolderRightsRisk": 1, "overallRisk": 10, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.1, "open": 2.1, "dayLow": 2.1, "dayHigh": 2.1, "regularMarketPreviousClose": 2.1, "regularMarketOpen": 2.1, "regularMarketDayLow": 2.1, "regularMarketDayHigh": 2.1, "payoutRatio": 0.0, "beta": 1.488, "volume": 1000, "regularMarketVolume": 1000, "averageVolume": 6568, "averageVolume10days": 4490, "averageDailyVolume10Day": 4490, "bid": 2.1, "ask": 2.37, "bidSize": 200, "askSize": 300, "marketCap": 725271360, "fiftyTwoWeekLow": 0.842, "fiftyTwoWeekHigh": 6.398, "priceToSalesTrailing12Months": 76.64425, "fiftyDayAverage": 2.2433, "twoHundredDayAverage": 2.23221, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 542751296, "profitMargins": 0.0, "floatShares": 237056381, "sharesOutstanding": 371934016, "heldPercentInsiders": 0.24123, "heldPercentInstitutions": 0.17155, "impliedSharesOutstanding": 372812992, "bookValue": 0.281, "priceToBook": 6.9395022, "lastFiscalYearEnd": 1751241600, "nextFiscalYearEnd": 1782777600, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -64295436, "trailingEps": -0.13, "enterpriseToRevenue": 57.356, "enterpriseToEbitda": -7.876, "52WeekChange": -0.5688702, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 1.95, "recommendationKey": "none", "totalCash": 84118352, "totalCashPerShare": 0.262, "ebitda": -68908944, "totalDebt": 0, "quickRatio": 9.077, "currentRatio": 9.693, "totalRevenue": 9462828, "revenuePerShare": 0.03, "returnOnAssets": -0.33764, "returnOnEquity": -0.54366, "grossProfits": 9462828, "freeCashflow": -33697940, "operatingCashflow": -54769024, "revenueGrowth": -0.216, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -8.231791, "financialCurrency": "AUD", "symbol": "CLRPF", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "hasPrePostMarketData": false, "firstTradeDateMilliseconds": 1723728600000, "regularMarketChangePercent": -7.142851, "regularMarketPrice": 1.95, "corporateActions": [], "regularMarketTime": 1756425600, "exchange": "PNK", "messageBoardId": "finmb_263530964", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "marketState": "CLOSED", "shortName": "Clarity Pharmaceuticals Ltd.", "longName": "Clarity Pharmaceuticals Ltd", "regularMarketChange": -0.14999986, "regularMarketDayRange": "2.1 - 2.1", "fullExchangeName": "OTC Markets OTCPK", "averageDailyVolume3Month": 6568, "fiftyTwoWeekLowChange": 1.108, "fiftyTwoWeekLowChangePercent": 1.3159145, "fiftyTwoWeekRange": "0.842 - 6.398", "fiftyTwoWeekHighChange": -4.448, "fiftyTwoWeekHighChangePercent": -0.69521725, "fiftyTwoWeekChangePercent": -56.88702, "earningsTimestampStart": 1755514740, "earningsTimestampEnd": 1756728000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.13, "fiftyDayAverageChange": -0.2932999, "fiftyDayAverageChangePercent": -0.13074484, "twoHundredDayAverageChange": -0.28220987, "twoHundredDayAverageChangePercent": -0.12642622, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Clarity Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]